Liftstream is an executive search recruitment company in the life sciences sector
Inhalable gene therapy may aid PAH patients
Authored by James Sheppard
Posted in Orphan Drugs and Rare Diseases
Tagged Cardiovascular Research Center, Circulation, congestive heart failure, europe, Gene therapy, Icahn School of Medicine, intervention, nebulizer-like inhalation device, PAH, Phase III study, pulmonary arterial hypertension, rat models, Roger Hajjar, SERCA2a enzyme, USA
Leave a comment
PAH franchise and cost cutting prevent Actelion from listing further
Authored by Karl Simpson
Posted in Orphan Drugs and Rare Diseases, Pharmaceutical business
Tagged Actelion, cost cutting, dual endothelin receptor antagonist, Elliott Advisors, FDA, GSK, Jean-Paul Clozel, JP Garnier, Opsumit, Orphan drugs, PAH, pulmonary arterial hypertension, rare diseases, Switzerland, Tracleer
Leave a comment